Accumulating evidence demonstrates the oncogenic roles of lncRNA (long non-coding RNA) molecules in a wide variety of cancer types including glioma. Equally important, However, tumorigenic functions of lncRNA in glioma remain largely unclear. A recent study suggested lncRNA SNHG15 played a role for regulating angiogenesis in glioma but its role in the tumor microenvironment (TME) was not investigated. First, we showed that SNHG15 was upregulated in GBM cells and associated with a poor prognosis for the patients of GBM using public databases. Next, we collected temozolomide sensitive (TMZ-S) and resistant (TMZ-R) clinical samples and demonstrated that co-culturing TMZ-R cells with HMC3 (microglial) cells promoted M2-polarization of HMC3 and the secretion of pro-GBM cytokines TGF-β and IL-6. Comparative qPCR analysis of TMZ-S and TMZ-R cells showed that a significantly higher level of SNHG15, coincidental with a higher level of Sox2, β-catenin, EGFR, and CDK6 in TMZ-R cells. Subsequently, using bioinformatics tool, a potential mechanistic route for SNHG15 to promote GBM tumorigenesis was by inhibiting tumor suppressor, miR-627-5p which leads to activation of CDK6. Gene-silencing technique was employed to demonstrate that suppression of SNHG15 indeed led to the suppression of GBM tumorigenesis, accompanied by an increase miR-627-5p and decreased its two oncogenic targets, CDK6 and SOX-2. In addition, SNHG15-silenced TMZ-R cells became significantly sensitive towards TMZ treatment and less capable of promoting M2-phenotype in the HMC3 microglial cells. We then evaluated the potential anti-GBM activity of CDK6 inhibitor, palbociclib, using TMZ-R PDX mouse models. Palbociclib treatment significantly reduced tumorigenesis in TMZ-R/HMC3 bearing mice and SNHG15 and CDK6 expression was significantly reduced while miR-627-5p level was increased. Additionally, palbociclib treatment appeared to overcome TMZ resistance as well as reduced M2 markers in HMC3 cells. Together, we provided evidence supporting the usage of CDK6 inhibitor for TMZ-resistant GBM cases. Further investigation is warranted for the consideration of clinical trials.

Glioblastoma (GBM) is one of the most common and malignant types of primary cancer in the central nervous system; however, the clinical outcomes of patients with GBM remain poor. Circular RNAs (circRNAs) have been revealed to serve important roles in diverse biological processes, such as regulating cell proliferation, epithelial‑mesenchymal transition and tumor development. However, the underlying biological function of circRNA filamin A (circFLNA) and its potential role in GBM remain to be determined. The present study aimed to identify differentially expressed circRNAs in GBM. Reverse transcription‑quantitative PCR was used to analyze the expression levels of circFLNA. The results demonstrated that the expression levels of circFLNA were significantly upregulated in clinical GBM samples and GBM cells compared with adjacent healthy brain tissues and normal human astrocytes, respectively. The results of the Cell Counting Kit‑8 and Transwell assays revealed that circFLNA knockdown significantly inhibited the proliferative and invasive abilities of GBM cell lines. Moreover, high circFLNA expression levels were associated with a worse prognosis in GBM. MicroRNA (miR)‑199‑3p was subsequently predicted to be target of circFLNA. The inhibitory effect of miR‑199‑3p on cell proliferation and invasion was partially reversed following circFLNA knockdown. In conclusion, the findings of the present study identified novel roles for circFLNA in GBM and indicated that the circFLNA/miR‑199‑3p signaling axis may serve an important role in GBM progression. Therefore, circFLNA may represent a novel target for the diagnosis and treatment of GBM.

The skin is the largest organ of the human body and, due to its direct contact with the external environment, is one of the most vulnerable tissues. Traditional medical bandages and gauze exhibit limited efficacy in wound management, often neglecting the control of wound inflammation and the promotion of skin regeneration. Hydrogels, as an emerging material, possess appropriate swelling capacity, oxygen permeability, and the ability to absorb wound exudates, thereby facilitating wound healing, making them an ideal choice for functional applications in skin tissue engineering. In this study, dual-treated balsa wood (BWSM) was used as the hydrogel substrate, with polyvinyl alcohol (PVA), chitosan (CS), and zinc gluconate (ZnG) used as the primary raw materials. The BWSM/PVA/CS/ZnG hydrogel was prepared via gamma-ray irradiation. Balsa wood treated with alkaline solutions, hydrogen peroxide solutions, and microwave treatment processing exhibited enhanced transparency, increased porosity, improved thermal stability and swelling rates, while retaining adequate mechanical strength. Gamma-ray irradiation of the BWSM/PVA/CS/ZnG hydrogel wound dressing demonstrated sustained drug release and antibacterial efficacy through release and antimicrobial tests. Animal experiments showed that the BWSM/PVA/CS/ZnG composite hydrogel promoted wound healing in mice and effectively prevented scar formation. The aforementioned results demonstrate that the PVA/CS/ZnG composite hydrogel loaded with balsa wood exhibits durable antibacterial properties and high mechanical strength and promotes wound healing, making it suitable for applications in biomedical materials such as wound dressings.